Articles dans des revues avec comité de lecture (3)
  1. 1. Negueruela Escudero, J., Vandenbempt, V., Talamantes, S., Ribeiro-Costa, F., Nunes, M., Marques Dias, A., Bansal, M., & Gurzov, E. N. (2024). Protocol for CRISPR-Cas12a genome editing of protein tyrosine phosphatases in human pluripotent stem cells and functional β-like cell generation. STAR Protocols, 5(3), 103297. doi:10.1016/j.xpro.2024.103297
  2. 2. Vandenbempt, V., Eski, S. E., Brahma, M. K., Li, A., Negueruela Escudero, J., Bruggeman, Y., Demine, S., Xiao, P., Cardozo, A. K., Baeyens, N., Martelotto, L., Singh, S. P., Mariño, E., Gysemans, C., & Gurzov, E. N. (2023). HAMSAB diet ameliorates dysfunctional signaling in pancreatic islets in autoimmune diabetes. iScience, 27(1), 108694. doi:10.1016/j.isci.2023.108694
  3. 3. Brahma, M. K., Xiao, P., Popa, M., Negueruela Escudero, J., Vandenbempt, V., Demine, S., Cardozo, A. K., & Gurzov, E. N. (2022). Nova1 or Bim Deficiency in Pancreatic β-Cells Does Not Alter Multiple Low-Dose Streptozotocin-Induced Diabetes and Diet-Induced Obesity in Mice. Nutrients, 14(18). doi:10.3390/nu14183866
    4.   Communications publiées lors de congrès ou colloques nationaux et internationaux (2)
  4. 1. Brahma, M. K., Xiao, P., Popa, M., Vandenbempt, V., Negueruela Escudero, J., Cardozo, A. K., & Gurzov, E. N. (2021). The Nova1-Bim axis in pancreatic beta-cells does not impact glucose homeostasis in obesity and multiple low-dose streptozotocin-induced diabetes. Diabetologia,(64 (Suppl 1):S1–S380). doi:10.1007/s00125-021-05519-y
  5. 2. Vandenbempt, V., Elvira Jimenez, B., Bauzá-Martinez, J., Negueruela Escudero, J., Ibrahim, H., Winder, M. M., Vekeriotaite, B., Singh, S. P., Rossello, F., Lybaert, P., Otonkoski, T., Gysemans, C., Wu, W., & Gurzov, E. N. (2021). PTPN2 regulates the interferon signalling in pancreatic beta-cells and its expression correlates with therapy outcome in autoimmune diabetes.